Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 6 studies | 34% ± 13% | |
B cell | 4 studies | 34% ± 7% | |
conventional dendritic cell | 4 studies | 34% ± 16% | |
endothelial cell | 4 studies | 30% ± 7% | |
plasmablast | 3 studies | 37% ± 14% | |
hematopoietic precursor cell | 3 studies | 27% ± 7% | |
myeloid cell | 3 studies | 33% ± 15% | |
ciliated cell | 3 studies | 34% ± 10% | |
GABAergic neuron | 3 studies | 33% ± 7% | |
glutamatergic neuron | 3 studies | 41% ± 11% | |
abnormal cell | 3 studies | 19% ± 3% | |
intestinal crypt stem cell | 3 studies | 21% ± 3% | |
erythrocyte | 3 studies | 51% ± 18% | |
basal cell | 3 studies | 35% ± 5% | |
transit amplifying cell | 3 studies | 40% ± 15% | |
erythroblast | 3 studies | 64% ± 24% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3750.58 | 1445 / 1445 | 100% | 129.99 | 183 / 183 |
intestine | 100% | 3321.03 | 966 / 966 | 100% | 137.14 | 527 / 527 |
stomach | 100% | 2353.77 | 359 / 359 | 100% | 129.02 | 286 / 286 |
ovary | 100% | 2545.11 | 180 / 180 | 100% | 85.43 | 429 / 430 |
bladder | 100% | 2517.10 | 21 / 21 | 100% | 116.99 | 502 / 504 |
breast | 100% | 2943.96 | 459 / 459 | 100% | 97.57 | 1113 / 1118 |
lung | 100% | 2785.18 | 576 / 578 | 100% | 109.85 | 1153 / 1155 |
prostate | 100% | 3147.10 | 245 / 245 | 99% | 64.78 | 498 / 502 |
brain | 100% | 2824.27 | 2640 / 2642 | 99% | 77.22 | 699 / 705 |
uterus | 99% | 2761.98 | 169 / 170 | 99% | 141.75 | 456 / 459 |
skin | 100% | 5848.24 | 1809 / 1809 | 98% | 76.81 | 462 / 472 |
thymus | 100% | 3865.28 | 653 / 653 | 98% | 59.85 | 592 / 605 |
pancreas | 96% | 1163.25 | 316 / 328 | 99% | 64.90 | 176 / 178 |
kidney | 100% | 2671.88 | 89 / 89 | 93% | 42.08 | 836 / 901 |
adrenal gland | 100% | 2335.46 | 258 / 258 | 87% | 38.31 | 199 / 230 |
liver | 100% | 1577.87 | 225 / 226 | 70% | 28.11 | 284 / 406 |
adipose | 100% | 2870.00 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 134.47 | 29 / 29 |
spleen | 100% | 3385.73 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 128.84 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 17.95 | 1 / 1 |
muscle | 100% | 2672.61 | 802 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 5089.41 | 925 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 97% | 1681.58 | 1296 / 1335 | 0% | 0 | 0 / 0 |
heart | 97% | 2280.69 | 835 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 90% | 33.00 | 72 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0008544 | Biological process | epidermis development |
GO_0070345 | Biological process | negative regulation of fat cell proliferation |
GO_0051091 | Biological process | positive regulation of DNA-binding transcription factor activity |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0043276 | Biological process | anoikis |
GO_1900087 | Biological process | positive regulation of G1/S transition of mitotic cell cycle |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_2000278 | Biological process | regulation of DNA biosynthetic process |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0035189 | Cellular component | Rb-E2F complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0090575 | Cellular component | RNA polymerase II transcription regulator complex |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0019904 | Molecular function | protein domain specific binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0000987 | Molecular function | cis-regulatory region sequence-specific DNA binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | TFDP1 |
Protein name | Transcription factor Dp-1 Transcription factor Dp-1 (DRTF1-polypeptide 1) (DRTF1) (E2F dimerization partner 1) |
Synonyms | DP1 |
Description | FUNCTION: Can stimulate E2F-dependent transcription. Binds DNA cooperatively with E2F family members through the E2 recognition site, 5'-TTTC[CG]CGC-3', found in the promoter region of a number of genes whose products are involved in cell cycle regulation or in DNA replication . The E2F1:DP complex appears to mediate both cell proliferation and apoptosis. Blocks adipocyte differentiation by repressing CEBPA binding to its target gene promoters . . |
Accessions | Q5JSB6 Q14186 ENST00000408980.6 Q5JSB5 ENST00000453989.2 F5H452 ENST00000544902.5 ENST00000375370.10 [Q14186-1] |